+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Topiramate"

Anti-Obesity Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Obesity Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 264 Pages
  • Global
From
From
From
Partial Epilepsy Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Partial Epilepsy Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Anti-Obesity Drugs Market Report and Forecast 2025-2034 - Product Thumbnail Image

Anti-Obesity Drugs Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Seizures Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Seizures Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Dravet Syndrome (DS) Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Dravet Syndrome (DS) Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

Topiramate is a drug used to treat a variety of neurological conditions, including epilepsy, migraine, and bipolar disorder. It is classified as an anticonvulsant and antiepileptic drug, and is used to reduce the frequency of seizures and to prevent migraine headaches. It is also used to treat bipolar disorder, as it can help to reduce the frequency and severity of manic episodes. Topiramate is a member of the Central Nervous System (CNS) drug class, which includes drugs used to treat neurological conditions. Topiramate is available in both generic and brand-name formulations, and is available in a variety of dosage forms, including tablets, capsules, and oral solutions. It is typically taken once or twice daily, depending on the condition being treated. Side effects of topiramate include dizziness, drowsiness, and nausea. The market for topiramate is highly competitive, with a number of major pharmaceutical companies offering the drug. Some of the companies in the market include Pfizer, GlaxoSmithKline, Johnson & Johnson, and Novartis. Show Less Read more